Reply of the Authors: Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

Fertil Steril. 2024 Apr;121(4):707. doi: 10.1016/j.fertnstert.2024.01.019. Epub 2024 Jan 23.

Authors

Scott M Nelson¹, Bart C J M Fauser², Juan Antonio García-Velasco³, Bjarke M Klein⁴, Joan-Carles Arce⁵

Affiliations

¹ School of Medicine, University of Glasgow, Glasgow, United Kingdom.
² Department of Reproductive Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
³ IVIRMA Global, Madrid, Spain.
⁴ Global Biometrics, Ferring Pharmaceuticals, Copenhagen, Denmark.
⁵ ReproStart, Copenhagen, Denmark.

PMID: 38266801
DOI: 10.1016/j.fertnstert.2024.01.019

No abstract available

Keywords: Follitropin delta; individualized dosing; in vitro fertilization; noninferiority trial; ovarian stimulation.

Publication types

Randomized Controlled Trial
Multicenter Study
Clinical Trial, Phase III
Letter

MeSH terms

Female
Fertilization in Vitro*
Follicle Stimulating Hormone, Human
Humans
Ovulation Induction*
Pregnancy
Pregnancy Rate
Recombinant Proteins

Substances

Recombinant Proteins
Follicle Stimulating Hormone, Human